Development of a New Diabetes Medication Self-Efficacy Scale and Its Association with Both Reported Problems in Using Diabetes Medications and Self-Reported Adherence
Cummings, Doyle M.. (June 2016).
Development of a New Diabetes Medication Self-Efficacy Scale and Its Association with Both Reported Problems in Using Diabetes Medications and Self-Reported Adherence.
Patient Preference and Adherence,
(1003–1010. Retrieved from
http://hdl.handle.net/10342/9739
Cummings, Doyle M..
"Development of a New Diabetes Medication Self-Efficacy Scale and Its Association with Both Reported Problems in Using Diabetes Medications and Self-Reported Adherence". Patient Preference and Adherence.
. (1003–1010.),
June 2016.
May 23, 2022.
http://hdl.handle.net/10342/9739.
Chicago:
Cummings, Doyle M.,
"Development of a New Diabetes Medication Self-Efficacy Scale and Its Association with Both Reported Problems in Using Diabetes Medications and Self-Reported Adherence," Patient Preference and Adherence 10, no.
(June 2016),
http://hdl.handle.net/10342/9739 (accessed
May 23, 2022).
AMA:
Cummings, Doyle M..
Development of a New Diabetes Medication Self-Efficacy Scale and Its Association with Both Reported Problems in Using Diabetes Medications and Self-Reported Adherence. Patient Preference and Adherence.
June 2016;
10()
1003–1010. http://hdl.handle.net/10342/9739. Accessed
May 23, 2022.
